Risk of developing fibroadenoma with the use of cyclosporine a in renal transplant recipients

Renal Failure

Volumn 27, Issue 6, 2005, Pages 721-725

  Binokay, Figen ^a   Balal, Mustafa ^a   Demir, Erkan ^a   Paydas, Saime ^a   Soyupak, Sureyya ^a   Sertdemir, Yasar ^a   Akgul, Erol ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Chronic renal failure (CRF); Cyclosporine A (Cyc A); Fibroadenoma; Renal transplantation; Ultrasonography

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; BREAST EXAMINATION; BREAST FIBROADENOMA; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG SAFETY; DRUG USE; ECHOMAMMOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT;

ADULT; BIOPSY, NEEDLE; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBROADENOMA; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; RENAL DIALYSIS; RISK ASSESSMENT; TRANSPLANTATION IMMUNOLOGY;

EID: 28644434173     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500243197     Document Type: Article

References (15)

1. Bargman JM. Neoplasia in dialysis patients: pathophysiology, epidemiology, and screening. Adv Perit Dial. 2000;16:93-96.
2. Baildam AD, Higgins RM, Hurley E, et al. Cyclosporine A and multiple fibroadenomas of the breast. Br J Surg. 1996;83:1755-1757.
3. Sangthawan P, Fox J, Atkins RJ, Kerr PG. Increased incidence of benign breast disease in female renal transplant patients receiving cyclosporine. ANZ J Surg. 2002;72:222.
4. Haberal M, Karakaya H, Emiroǧlu R, Basaran O, Moray G, Bilgin N. Malignant tumors after renal tranplantation. Artif. Organs 2002;26:778.
5. Amshel CE, Sibley E. Multiple unilateral fibroadenomas. Breast J. 2001;7:189.
6. Nelson ZC, Ray RM, Gao DL, Thomas DB. Risk factors for fibroadenoma in a cohort of female textile workers in Shangai, China. Am J Epidemiol. 2002;157:599-605.
7. Weinstein D. Breast fibroadenoma: mapping. Radiology. 1999;210:233-240.
8. Geller BM, Barlow WE, Ballard-Barbash R, et al. Use of the American College of Radiology BIRADS to report on the mammographie evaluation of women with signs and symptoms of breast disease. Radiology. 2002;22:536-542.
9. Kyllönen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population. Transpl Int. 2000;13:394-398.
10. Berg WA, Campassi CI, Ioffe OB. Cystic lesions of the breast: sonographic-pathologic correlation. Radiology. 2003;227:183-191.
11. Weinstein SP, Orel SG, Collazzo I, Conant EF, Lawton TJ, Czerniecki B. Cyclosporin-A induced fibroadenomas of the breast: report of five cases. Radiology. 2000;220:465-468.
12. Takei H, Lino Y, Horiguchi J, et al. Natural history of fibroadenomas based on the correlation between size and patient age. Jpn J Clin Oncol. 1999;29:8-10.
13. Muttarak M, Peh W, Chaiwun B, Lumlertgul D. Multiple bilateral giant fibroadenomas associated with cyclosporine A therapy in a renal transplant recipient. Australas Radiol 2001;45:517-519.
14. Rolles K, Calne RY. Two cases of benign lumps after treatment with cyclosporin A. Lancet 1980;2:795.
15. Campbell A, Moazami N, Ditkoff BA, Kurtz E, Estabrook A, Schnabel F. Short-term outcome of chronic immunosuppression on the development of breast lesions in premenopausal heart and lung transplant patients. J Surg Res. 1998;78:27-30.